<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR20">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tavares</surname>
    <given-names>LP</given-names>
   </name>
   <name>
    <surname>Garcia</surname>
    <given-names>CC</given-names>
   </name>
   <name>
    <surname>Machado</surname>
    <given-names>MG</given-names>
   </name>
   <name>
    <surname>Queiroz-Junior</surname>
    <given-names>CM</given-names>
   </name>
   <name>
    <surname>Barthelemy</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Trottein</surname>
    <given-names>F</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>CXCR1/2 antagonism is protective during Influenza and post-influenza pneumococcal infection</article-title>
  <source>Front Immunol</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>1799</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2017.01799</pub-id>
  <?supplied-pmid 29326698?>
  <pub-id pub-id-type="pmid">29326698</pub-id>
 </element-citation>
</ref>
